11:30 - 12:00 Section 112 Introduction and Overview
- Jeanne Fromer, New York University School of Law and Engelberg Center on Innovation Law & Policy
- Bruce Wexler, Paul Hastings
12:15 - 1:15 Lunch Discussion of Amgen
- John Desmarais (Moderator), Desmarais LLP
- Judge Kathleen O’Malley, Irell and Manella LLP
- Lisa Pensabene, O’Melveny & Myers
- Jonathan E. Singer, Fish and Richardson
1:15 - 2:15 Section 112 in the Life Sciences
- Bruce Wexler (Moderator), Paul Hastings
- Henry Hadad, Bristol-Myers Squibb
- Amy Nelson, Office of the Solicitor, U.S. Patent and Trademark Office
- E. Joshua Rosenkranz, Orrick
2:30 - 3:30 Section 112 in Technology
- Laura Sheridan (Moderator), Google
- Isabella Fu, Microsoft
- David J. Kappos, Cravath, Swaine & Moore LLP
- Natalie S. Richer, Lerner David
3:30 - 4:30 Guiding Principles Going Forward
- Scott Hemphill (Moderator), New York University School of Law and Engelberg Center on Innovation Law & Policy
- Paul R. Gugliuzza, Temple University Beasley School of Law
- Nathan Kelley, Perkins Coie
- Erin Mehta, Northrop Grumman
This event will not be livestreamed. However, we will publish the audio file on our podcast page here for your enjoyment a week after the event. This event has been approved for 4.5 New York State CLE credits in the category of Areas of Professional Practice. The credit is both transitional and non-transitional; it is appropriate for both experienced and newly admitted attorneys.
Click here to find the CLE readings for each panel.
Lunch will be provided.
This event is governed by the Engelberg Center’s Code of Conduct and NYU’s COVID policies.